94 related articles for article (PubMed ID: 1684372)
1. In vivo induction of cytotoxic T cell response by a free synthetic peptide requires CD4+ T cell help.
Fayolle C; Deriaud E; Leclerc C
J Immunol; 1991 Dec; 147(12):4069-73. PubMed ID: 1684372
[TBL] [Abstract][Full Text] [Related]
2. Herpes simplex virus class I-restricted peptide induces cytotoxic T lymphocytes in vivo independent of CD4+ T cells.
Vasilakos JP; Michael JG
J Immunol; 1993 Mar; 150(6):2346-55. PubMed ID: 8095512
[TBL] [Abstract][Full Text] [Related]
3. Priming of influenza virus-specific cytotoxic T lymphocytes vivo by short synthetic peptides.
Gao XM; Zheng B; Liew FY; Brett S; Tite J
J Immunol; 1991 Nov; 147(10):3268-73. PubMed ID: 1682377
[TBL] [Abstract][Full Text] [Related]
4. Identification of a ras oncogene peptide that contains both CD4(+) and CD8(+) T cell epitopes in a nested configuration and elicits both T cell subset responses by peptide or DNA immunization.
Bristol JA; Orsini C; Lindinger P; Thalhamer J; Abrams SI
Cell Immunol; 2000 Nov; 205(2):73-83. PubMed ID: 11104579
[TBL] [Abstract][Full Text] [Related]
5. CD4+ T helper cell response is required for memory in CD8+ T lymphocytes induced by a poly(I:C)-adjuvanted MHC I-restricted peptide epitope.
Qiu F; Cui Z
J Immunother; 2007; 30(2):180-9. PubMed ID: 17471165
[TBL] [Abstract][Full Text] [Related]
6. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
Wild J; Grusby MJ; Schirmbeck R; Reimann J
J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
[TBL] [Abstract][Full Text] [Related]
7. Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides.
Franke ED; Corradin G; Hoffman SL
J Immunol; 1997 Oct; 159(7):3424-33. PubMed ID: 9317141
[TBL] [Abstract][Full Text] [Related]
8. Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction.
Hirsch R; Archibald J; Gress RE
J Immunol; 1991 Oct; 147(7):2088-93. PubMed ID: 1833451
[TBL] [Abstract][Full Text] [Related]
9. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.
Shirai M; Pendleton CD; Ahlers J; Takeshita T; Newman M; Berzofsky JA
J Immunol; 1994 Jan; 152(2):549-56. PubMed ID: 8283036
[TBL] [Abstract][Full Text] [Related]
10. Costimulation of tumor-reactive CD4+ and CD8+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma.
Li Y; McGowan P; Hellström I; Hellström KE; Chen L
J Immunol; 1994 Jul; 153(1):421-8. PubMed ID: 7515929
[TBL] [Abstract][Full Text] [Related]
11. Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo.
Schirmbeck R; Melber K; Kuhröber A; Janowicz ZA; Reimann J
J Immunol; 1994 Feb; 152(3):1110-9. PubMed ID: 8301120
[TBL] [Abstract][Full Text] [Related]
12. Synthetic peptide in mineral oil adjuvant elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes in rhesus monkeys.
Yasutomi Y; Palker TJ; Gardner MB; Haynes BF; Letvin NL
J Immunol; 1993 Nov; 151(9):5096-105. PubMed ID: 7691965
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC.
Maecker HT; Umetsu DT; DeKruyff RH; Levy S
J Immunol; 1998 Dec; 161(12):6532-6. PubMed ID: 9862678
[TBL] [Abstract][Full Text] [Related]
14. In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying viral CD8+ T cell epitopes.
Fayolle C; Sebo P; Ladant D; Ullmann A; Leclerc C
J Immunol; 1996 Jun; 156(12):4697-706. PubMed ID: 8648115
[TBL] [Abstract][Full Text] [Related]
15. Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells.
May RJ; Dao T; Pinilla-Ibarz J; Korontsvit T; Zakhaleva V; Zhang RH; Maslak P; Scheinberg DA
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4547-55. PubMed ID: 17671141
[TBL] [Abstract][Full Text] [Related]
16. Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells.
Buller RM; Holmes KL; Hügin A; Frederickson TN; Morse HC
Nature; 1987 Jul 2-8; 328(6125):77-9. PubMed ID: 2955227
[TBL] [Abstract][Full Text] [Related]
17. Cross-reactive cytotoxic T lymphocytes induced by V3 loop synthetic peptides from different strains of human immunodeficiency virus type 1.
Casement KS; Nehete PN; Arlinghaus RB; Sastry KJ
Virology; 1995 Aug; 211(1):261-7. PubMed ID: 7645219
[TBL] [Abstract][Full Text] [Related]
18. Priming antiviral cytotoxic T lymphocytes: requirement for CD4+ cells is dependent on the antigen presenting cell in vivo.
Ciavarra RP; Tedeschi B
Cell Immunol; 1994 Aug; 157(1):132-43. PubMed ID: 7913664
[TBL] [Abstract][Full Text] [Related]
19. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.
Schmid DS; Rouse BT
J Immunol; 1983 Jul; 131(1):479-84. PubMed ID: 6223080
[TBL] [Abstract][Full Text] [Related]
20. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy.
Diehl L; den Boer AT; Schoenberger SP; van der Voort EI; Schumacher TN; Melief CJ; Offringa R; Toes RE
Nat Med; 1999 Jul; 5(7):774-9. PubMed ID: 10395322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
